STRS Ohio’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

STRS Ohio’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,300	Closed	-$14K	–	2338
2020 Q3	$14K	Hold	1,300	–	–	﹤0.01%	2118
2020 Q2	$9K	Hold	1,300	–	–	﹤0.01%	2108
2020 Q1	$7K	Hold	1,300	–	–	﹤0.01%	1962
2019 Q4	$6K	Hold	1,300	–	–	﹤0.01%	2026
2019 Q3	$9K	Hold	1,300	–	–	﹤0.01%	2031
2019 Q2	$15K	Buy	+1,300	New	+$18.9K	﹤0.01%	2054

Other funds holding KLDO

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STRS Ohio's KLDO Position: Q4 2020 in Review

STRS Ohio sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q4 2020, closing a stake of 1,300 shares — an estimated $14K sold.

STRS Ohio first reported a position in KLDO in Q2 2019 and held it in 6 quarters. The position peaked at $15K in Q2 2019. 61 funds tracked by Wall St. Rank hold KLDO as of Q4 2020.

STRS Ohio reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
STRS Ohio sold 1,300 Kaleido Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $14K.
STRS Ohio first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 6 quarters.
STRS Ohio's Kaleido Biosciences, Inc. Common Stock position peaked at $15K in Q2 2019.
61 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.